Comparative effectiveness of antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus: Analysis of 12,589 consecutive cases from 287 US hospital systems

Journal of Neurosurgery

Volumn 122, Issue 2, 2015, Pages 443-448

  Parker, Scott L ^a   McGirt, Matthew J ^a,d   Murphy, Jeffrey A ^b   Megerian, J Thomas ^c   Stout, Michael ^b   Engelhart, Luella ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Johnson Johnson Company   (United States)

^c Research and Development Department of Codman and Shurtleff Inc   (United States)

^d CAROLINA NEUROSURGERY AND SPINE ASSOCIATES   (United States)

Author keywords

Antibiotic impregnated; Hydrocephalus; Infection; Shunt

Indexed keywords

CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; LINEZOLID; MEROPENEM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC IMPREGNATED VENTRICULAR SHUNT CATHETER; ARTICLE; CATHETER; CATHETER INFECTION; CHILD; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HOSPITAL BILLING; HOSPITAL DISCHARGE; HUMAN; HYDROCEPHALUS; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SHUNT INFECTION; UNITED STATES; ADOLESCENT; ADVERSE EFFECTS; AGED; BACTERIAL INFECTIONS; CEREBROSPINAL FLUID SHUNTING; COMPARATIVE STUDY; DEVICES; INCIDENCE; LONGITUDINAL STUDY; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; RETROSPECTIVE STUDY; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; VERY ELDERLY;

ADOLESCENT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CATHETERS; CEREBROSPINAL FLUID SHUNTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYDROCEPHALUS; INCIDENCE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84926096832     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2014.10.JNS13395     Document Type: Article

References (50)

1. Abed WT, Alavijeh MS, Bayston R, Shorvon SD, Patsalos PN: An evaluation of the epileptogenic properties of a rifampicin/clindamycin-impregnated shunt catheter. Br J Neurosurg 8:725-730, 1994
2. Albanese A, De Bonis P, Sabatino G, Capone G, Marchese E, Vignati A, et al: Antibiotic-impregnated ventriculo-peritoneal shunts in patients at high risk of infection. Acta Neurochir (Wien) 151:1259-1263, 2009
3. Ammirati M, Raimondi AJ: Cerebrospinal fluid shunt infections in children. A study on the relationship between the etiology of hydrocephalus, age at the time of shunt placement, and infection rate. Childs Nerv Syst 3:106-109, 1987
4. Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML: Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst 21:56-61, 2005
5. Attenello FJ, Garces-Ambrossi GL, Zaidi HA, Sciubba DM, Jallo GI: Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters. Neurosurgery 66:284-289, 2010
6. Bayston R: The antibacterial effects of impregnated silastic and its possible applications in surgery. J Pediatr Surg 12:55-61, 1977
7. Bayston R: Preliminary studies on the impregnation of silastic elastomers with antimicrobial substances. Dev Med Child Neurol Suppl 18:50-54, 1976
8. Bayston R, Ashraf W, Bhundia C: Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother 53:778-782, 2004
9. Bayston R, Grove N, Siegel J, Lawellin D, Barsham S: Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 52:605-609, 1989
10. Bayston R, Lambert E: Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg 87:247-251, 1997
11. Bayston R, Lari J: A study of the sources of infection in colonised shunts. Dev Med Child Neurol 16 (6 Suppl 32):16-22, 1974
12. Blount JP, Campbell JA, Haines SJ: Complications in ventricular cerebrospinal fluid shunting. Neurosurg Clin N Am 4:633-656, 1993
13. Borgbjerg BM, Gjerris F, Albeck MJ, Børgesen SE: Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 136:1-7, 1995
14. Borges LF: Cerebrospinal fluid shunts interfere with host defenses. Neurosurgery 10:55-60, 1982
15. Burke TA, Wisniewski T, Ernst FR: Resource utilization and costs associated with chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy administered in the US outpatient hospital setting. Support Care Cancer 19:131-140, 2011
16. Chapman PH, Borges LF: Shunt infections: prevention and treatment. Clin Neurosurg 32:652-664, 1985
17. Choux M, Genitori L, Lang D, Lena G: Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 77:875-880, 1992
18. Darouiche RO: Treatment of infections associated with surgical implants. N Engl J Med 350:1422-1429, 2004
19. Erşahin Y, Mutluer S, Güzelbaʇ E: Cerebrospinal fluid shunt infections. J Neurosurg Sci 38:161-165, 1994
20. Eymann R, Chehab S, Strowitzki M, Steudel WI, Kiefer M: Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters. J Neurosurg Pediatr 1:444-450, 2008
21. Fan-Havard P, Nahata MC: Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharm 6:866-880, 1987
22. Farber SH, Parker SL, Adogwa O, McGirt MJ, Rigamonti D: Effect of antibiotic-impregnated shunts on infection rate in adult hydrocephalus: a single institution's experience. Neurosurgery 69:625-629, 2011
23. Farber SH, Parker SL, Adogwa O, Rigamonti D, McGirt MJ: Cost analysis of antibiotic-impregnated catheters in the treatment of hydrocephalus in adult patients. World Neurosurg 74:528-531, 2010
24. Gardner P, Leipzig T, Phillips P: Infections of central nervous system shunts. Med Clin North Am 69:297-314, 1985
25. Govender ST, Nathoo N, van Dellen JR: Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 99:831-839, 2003
26. Gray ED, Peters G, Verstegen M, Regelmann WE: Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet 1:365-367, 1984
27. Hampl J, Schierholz J, Jansen B, Aschoff A: In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections. Acta Neurochir (Wien) 133:147-152, 1995
28. Hayhurst C, Cooke R, Williams D, Kandasamy J, O'Brien DF, Mallucci CL: The impact of antibiotic-impregnated catheters on shunt infection in children and neonates. Childs Nerv Syst 24:557-562, 2008
29. Kockro RA, Hampl JA, Jansen B, Peters G, Scheihing M, Giacomelli R, et al: Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters. J Med Microbiol 49:441-450, 2000
30. Kohnen W, Schäper J, Klein O, Tieke B, Jansen B: A silicone ventricular catheter coated with a combination of rifampin and trimethoprim for the prevention of catheter-related infections. Zentralbl Bakteriol 287:147-156, 1998
31. Kulkarni AV, Drake JM, Lamberti-Pasculli M: Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 94:195-201, 2001
32. Mancao M, Miller C, Cochrane B, Hoff C, Sauter K, Weber E: Cerebrospinal fluid shunt infections in infants and children in Mobile, Alabama. Acta Paediatr 87:667-670, 1998
33. McGirt MJ, Woodworth G, Coon AL, Thomas G, Williams MA, Rigamonti D: Diagnosis, treatment, and analysis of long-term outcomes in idiopathic normal-pressure hydrocephalus. Neurosurgery 57:699-705, 2005
34. McGirt MJ, Woodworth G, Thomas G, Miller N, Williams M, Rigamonti D: Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg 101:627-632, 2004
35. Odio C, McCracken GH Jr, Nelson JD: CSF shunt infections in pediatrics. A seven-year experience. Am J Dis Child 138:1103-1108, 1984
36. Parker SL, Anderson WN, Lilienfeld S, Megerian JT, McGirt MJ: Cerebrospinal shunt infection in patients receiving antibiotic-impregnated versus standard shunts. A review. J Neurosurg Pediatr 8:259-265, 2011
37. Parker SL, Attenello FJ, Sciubba DM, Garces-Ambrossi GL, Ahn E, Weingart J, et al: Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts. Childs Nerv Syst 25:77-83, 2009
38. Patetta M: Survival Analysis Using the Proportional Hazards Model: Course Notes. Cary, NC: SAS Institute, 2001, p 151
39. Patwardhan RV, Nanda A: Implanted ventricular shunts in the United States: the billion-dollar-a-year cost of hydrocephalus treatment. Neurosurgery 56:139-145, 2005
40. Peters G, Locci R, Pulverer G: Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis 146:479-482, 1982
41. Pople IK, Bayston R, Hayward RD: Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg 77:29-36, 1992
42. Puca A, Anile C, Maira G, Rossi G: Cerebrospinal fluid shunting for hydrocephalus in the adult: factors related to shunt revision. Neurosurgery 29:822-826, 1991
43. Renier D, Lacombe J, Pierre-Kahn A, Sainte-Rose C, Hirsch JF: Factors causing acute shunt infection. Computer analysis of 1174 operations. J Neurosurg 61:1072-1078, 1984
44. Richards HK, Seeley HM, Pickard JD: Efficacy of antibiotic-impregnated shunt catheters in reducing shunt infection: data from the United Kingdom Shunt Registry. Clinical article. J Neurosurg Pediatr 4:389-393, 2009
45. Rogers EA, Kimia A, Madsen JR, Nigrovic LE, Neuman MI: Predictors of ventricular shunt infection among children presenting to a pediatric emergency department. Pediatr Emerg Care 28:405-409, 2012
46. Sciubba DM, McGirt MJ, Woodworth GF, Carson B, Jallo GI: Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst 23:867-871, 2007
47. Sciubba DM, Noggle JC, Carson BS, Jallo GI: Antibiotic-impregnated shunt catheters for the treatment of infantile hydrocephalus. Pediatr Neurosurg 44:91-96, 2008
48. Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, et al: Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg 103 (2 Suppl):131-136, 2005
49. Thomas R, Lee S, Patole S, Rao S: Antibiotic-impregnated catheters for the prevention of CSF shunt infections: a systematic review and meta-analysis. Br J Neurosurg 26:175-184, 2012
50. Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP: Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 60:1014-1021, 1984